You are on page 1of 18

Venture Capital Report

Europe | 4Q | 2015

VENTURE CAPITAL REPORT

VENTURE CAPITAL REPORT

The following report presents Dow Jones VentureSources quarterly findings for European venture capital fundraising, investment, valuation,
and liquidity. The included charts and graphs offer a comprehensive view of the trends currently affecting the venture capital market.
Highlights for 4Q 2015 include:

European venture capital fundraising and fund closings climbed from prior quarter;

Venture capital investment into European companies declined from 3Q 2015, while the number of deals improved;

The number of mergers and acquisitions (M&As) experienced a decrease from the last quarter, while the number of initial public offerings (IPOs)
is on the rise.

VENTURE CAPITAL REPORT

EUROPEAN VENTURE CAPITAL FUNDRAISING


RISES IN 4Q 2015
FUNDRAISING

19 European venture capital funds raised


1.33 billion during 4Q 2015, both a 58% climb in capital raised
and number of fund closings from 3Q 2015 .

Compared with the same period last year, euros raised


improved by 6%, despite the number of
fund closing dropped 30%.
Sofinnova Capital VIII was the largest fund of this quarter,
which raised 300 million, accounting for 23% of the total
amount raised for 4Q 2015.

European VC Fundraising
Based on multiple closings (20122015)
45

2.50

40
2.00

35
30

1.50

25
20

1.00

15
10

0.50

5
0
Amount Raised (B)
Number of Funds

4Q'12

1Q'13

2Q'13

3Q'13

4Q'13

1Q'14

2Q'14

3Q'14

4Q'14

1Q'15

1.42 0.76 1.03 0.65 1.94 0.55 1.26 0.81 1.26 1.06
32

15

17

12

41

22

24

20

27

22

2Q'15

3Q'15

0.00

4Q'15

1.96 0.84 1.33


26

12

19

VENTURE CAPITAL REPORT

LARGEST EUROPEAN VC FUNDS RAISED IN 4Q 2015


FUNDRAISING

Firm Name

Fund Name

Amount (M)

Location

Offering
Status

Fund Type

Fund Category

Closing Type

Sofinnova Partners

Sofinnova Capital VIII

300.00

Paris,
France

Closed

Early-stage venture
capital

Venture Capital

Final

Acton Capital Partners

Heureka Growth Fund II

170.00

Munich,
Germany

Closed

Late-stage venture
capital

Venture Capital

Final

Partech Ventures

Partech Growth

170.00

Paris,
France

Open

Late-stage venture
capital

Venture Capital

Octopus Ventures Ltd.

Octopus Zenith Opportunities II


LP

121.62

London,
United Kingdom

Closed

Late-stage venture
capital

Venture Capital

Open Ocean Capital

Open Ocean Capital Software


Fund

100

Espoo,
Finland

Closed

Early-stage venture
capital

Venture Capital

First

Final

Final

VENTURE CAPITAL REPORT

INVESTMENT INTO EUROPEAN VENTURE-BACKED


COMPANIES DECLINED IN 4Q 2015
FINANCING

European companies raised over 3.3 billion for 426 deals during
4Q 2015, a 1% decline in the amount raised from the prior quarter
despite a 14% rise in the number of deals.

Compared with the year ago period, both investment amount


and the number of deals improved, raising 61% and 4%
respectively.
Information Technology was the strongest sector of the
quarter in terms of attracting investment.

Equity Financings into Europe-based,


VC-backed Companies (20122015)
4.00

500
450

3.50

400

3.00

350

2.50

300

2.00

250
200

1.50

150

1.00

100

0.50
0.00

50
4Q'12

1Q'13

2Q'13 3Q'13 4Q'13

1Q'14

2Q'14 3Q'14 4Q'14

1Q'15

2Q'15 3Q'15 4Q'15

Amount Raised (B) 1.28 1.24 1.54 1.80 1.98 1.64 2.43 2.32 2.05 2.83 3.52 3.32 3.29
Number of Deals

405

391

434

410

499

412

450

361

411

405

393

374

VENTURE CAPITAL REPORT

426

EQUITY FINANCINGS INTO EUROPE-BASED, VC-BACKED


COMPANIES, BY ROUND CLASS (20122015) NUMBER
OF DEALS
FINANCING
240
200
160
120
80
40
0

4Q'12

1Q'13

2Q'13

3Q'13

4Q'13

1Q'14

2Q'14

3Q'14

4Q'14

1Q'15

2Q'15

3Q'15

Seed

66

41

40

57

75

39

32

26

35

21

26

26

4Q'15
29

First

200

205

215

213

223

219

227

182

200

204

179

178

229

Second

61

66

87

65

85

64

92

66

76

79

73

78

82

Later

45

54

65

51

82

60

78

62

60

79

96

75

62

Restart

VENTURE CAPITAL REPORT

EQUITY FINANCINGS INTO EUROPE-BASED, VC-BACKED


COMPANIES, BY ROUND CLASS (20122015) AMOUNT
RAISED (M)
FINANCING
2,500

2,000

1,500

1,000

500

4Q'12

1Q'13

2Q'13

3Q'13

4Q'13

1Q'14

2Q'14

3Q'14

4Q'14

1Q'15

2Q'15

3Q'15

Seed

27

21

17

23

31

18

22

15

27

16

17

29

20

First

464

401

429

543

491

513

625

461

453

606

509

808

725

Second

299

258

472

706

402

306

477

220

775

451

922

571

578

Later

458

540

600

461

995

679

1,124

900

751

1,691

1,937

1,861

1,511

Restart

4Q'15

VENTURE CAPITAL REPORT

EQUITY FINANCINGS INTO EUROPE-BASED,


VC-BACKED COMPANIES (20122015)
MEDIAN EQUITY DEAL SIZE (M)
FINANCING
3.00

2.50

2.00

1.50

1.00

0.50

0.00
Median Equity Deal Size (M)

4Q'12

1Q'13

2Q'13

3Q'13

4Q'13

1Q'14

2Q'14

3Q'14

4Q'14

1Q'15

2Q'15

3Q'15

4Q'15

1.20

1.39

1.52

1.00

1.25

1.50

1.74

1.58

2.00

1.98

2.50

2.30

2.22

VENTURE CAPITAL REPORT

EQUITY FINANCINGS INTO EUROPE-BASED,


VC-BACKED COMPANIES, BY INDUSTRY GROUP (4Q 2015)
FINANCING

Information Technology received the largest allocation of investment during 4Q


2015, raising 840 million through 107 deals. The sector attracted a 26% of the
total amount invested and a 25% of all deals completed for the quarter.

4Q'15 Industry
Breakdown
By Number
of Deals

Business and Financial Services


25%

Consumer Goods
Consumer Services
3%

1%

Energy & Utilities


Healthcare

Consumer Services ranked the second highest proportion of investment. The


sector garnered 802 million across 110 deals, an improvement of 4% in deal
number while a 14% decline in amount invested from 3Q 2015.
Healthcare placed third, receiving 752 million across 73 deals. The sectors
investment figure represents a 23% of the total equity financing into European
VC-backed companies for 4Q 2015.

23%

17%

26%
2%

4Q15 Industry
Breakdown
By Amount
Raised

Industrial Goods & Materials


Information Technology

Business and Financial Services


22%

26%

Consumer Goods
1%

3%

Consumer Services
Energy & Utilities
Healthcare

24%
23%

1%

Industrial Goods & Materials


Information Technology

VENTURE CAPITAL REPORT

TOP 5 DEALS INTO EUROPEAN VC-BACKED


COMPANIES (4Q 2015)
FINANCING

Co. Name

Location

O3B Networks
Ltd.

St. Helier,
United
Kingdom

Industry
Code

Wireless
Telecommunic Communications and
ations Service
Networking
Providers

Skyscanner Ltd.

Edinburgh,
United
Kingdom

Search Portals

auxmoney
GmbH

Gdusseldorf,
Germany

Lending

CureVac AG

Industry
Segment

Consumer
Information Services

Brief
Description

Close
Date

Round
Type

Raised
(M)

Round Investors
(* denotes lead)

Information
Technology

Provider of global satellite


services.

10/12/2015

5th
Round

427.83

Allen & Co. LLC, Development Bank of Southern


Africa, Google Ventures, HSBC Investments, Liberty
Global, Luxempart SA, North Bridge Venture
Partners, Satya Capital LLP, SES SA, Sofina SA.

Provider of an online travel search


31/12/2015
engine.

Later
Round

179.94

Artemis Ventures, Baillie Gifford & Co. Ltd.,


Khazanah Nasional Berhad*, Vitruvian Partners
LLP, Yahoo Japan Corp.*

Corporate

150

Aegon*

Later
Round

100

Baillie Gifford & Co. Ltd.*, Chartwave Ltd., Coppel


Family, Elma Investments, Northview LifeSciences,
Sigma Group

Corporate

93.78

Vertex Pharmaceuticals*

Consumer Services

Financial Institutions Business and Financial Provider of an online peer-to-peer


20/10/2015
(P2P) lending marketplace.
and Services
Services

Tuebingen, Biotechnology
Biopharmaceuticals
Germany
Therapeutics

Crispr
Basel,
Therapeutics AG Switzerland

Industry
Group

Biotechnology
Therapeutics Biopharmaceuticals

Healthcare

Developer of messenger RNA


(mRNA)-based therapeutics and
prophylactic vaccines.

Healthcare

Developer of genome-editing
technologies for the treatment of 26/10/2015
serious human genetic diseases.

29/10/2015

VENTURE CAPITAL REPORT

10

MOST ACTIVE INVESTORS FOR EUROPE-BASED,


VC-BACKED COMPANIES (4Q 2015) BY DEALS COMPLETED
FINANCING
16

16

14
12

11

10
8
8

7
6

Seedcamp

Mercia Technologies
PLC

Index Ventures

6
4
2
0

High-Tech
Bpifrance Investment
Gruenderfonds
Management GmbH

Partech Ventures

Idinvest Partners

VENTURE CAPITAL REPORT

11

EQUITY FINANCINGS INTO EUROPE-BASED,


VC-BACKED COMPANIES BY COUNTRY (4Q 2015)
FINANCING
Number of
Deals in 4Q 2015
by Country
(Top 4)

The United Kingdom remained as the most favoured destination for equity
financing during 4Q 2015, receiving 1403 million across 111 deals. The country
took 43% of all equity financing from 4Q 2015.
Germany ranked second. It reached a total 685 million through 78 deals,
representing a 21% share of European financing. A 92% rise in capital invested
and 11% increase of the number of deals from last quarter.
France occupied third position raising 379 million, 12% of the total for the
quarter. Switzerland placed fourth ,raising 316 million during 4Q 2015.

United Kingdom
26%

29%

France
Germany
6%

23%

21%

Spain

18%
Rest of Europe

Amount Raised
in 4Q 2015
by Country
(Top 4)

United Kingdom

15%

Germany

10%

43%
France
19%

11%

Switzerland
21%

Rest of Europe

VENTURE CAPITAL REPORT

12

EUROPE 4Q 2015 VENTURE EXIT ACTIVITY


LIQUIDITY

Exit Opportunities for European VCbacked Companies (20122015)

38 venture-backed M&As took place in Europe


during 4Q 2015, a 22% decrease from 3Q 2015 as well as
from 4Q 2014.
Total amount raised through European VC-backed
M&As in 4Q 2015 is 6.7 billion. A 28% rise from the prior
quarter and more than doubled from the same period
last year.
13 venture-backed IPOs took place during 4Q 2015, a
63% and 30% increase from 3Q 2015 and 4Q 2014
respectively.

4Q'15
3Q'15
2Q'15
1Q'15
4Q'14
3Q'14
2Q'14
1Q'14
4Q'13
3Q'13
2Q'13
1Q'13
4Q'12
0
4Q'12

10
1Q'13

2Q'13

20
3Q'13

4Q'13

30
1Q'14

2Q'14

40
3Q'14

4Q'14

50
1Q'15

2Q'15

60
3Q'15

70
4Q'15

IPOs

21

16

10

12

15

13

M&As

47

37

40

42

44

56

42

50

49

53

43

49

38

VENTURE CAPITAL REPORT

13

TOP 3 M&As IN EUROPE (4Q 2015)


LIQUIDITY

Company Name

Location

Brief
Description

Industry
Code

Industry Segment

Industry Group

Close
Date

Round
Type

Amount Paid
(M)

Acquirer

Acerta Pharma
B.V.

Oss,
Netherlands

Developer of therapies intended


for the treatment of cancer and
autoimmune diseases.

Biotechnology
Therapeutics

Biopharmaceuticals

Healthcare

17/12/2015

Acquisition

2296.03

AstraZeneca Plc

Dezima Pharma
B.V.

Naarden,
Netherlands

Developer of drugs to treat


dyslipidemia.

Pharmaceuticals

Biopharmaceuticals

Healthcare

16/10/2015

Acquisition

1339.76

Amgen Inc.

Avito.ru

Moscow,
Russia

Provider of a classified
advertising website.

Shopping
Facilitators

23/10/2015

Acquisition

1071.81

Naspers

Consumer
Consumer Services
Information Services

VENTURE CAPITAL REPORT

14

EUROPEAN VC-BACKED IPOs (2012-2015)


LIQUIDITY

13 venture-backed companies went public during 4Q 2015,


an increase in number of deals from the prior quarter while
the amount raised declined.

2,500.00

25

2,000.00

20

1,500.00

15

1,000.00

10

IPOs raised 511 million during 4Q 2015, a decline of 27%


from the 700 million raised in 3Q 2015.
The largest European VC-backed IPO of 4Q 2015
was the NovoCure Ltd. The company raised 147 million
for its offering on Nasdaq.

500.00

0.00

4Q'12

1Q'13

Raised (M) through IPO 142.99 19.22


Number of IPOs

2Q'13
89.24
5

3Q'13

4Q'13

1Q'14

2Q'14

3Q'14

4Q'14

1Q'15

2Q'15

3Q'15

4Q'15

25.51 366.10 448.63 529.53 447.47 2,250 417.40 533.10 699.69 511.42
3

21

16

10

12

15

VENTURE CAPITAL REPORT

13

15

TOP 3 IPOs IN EUROPE (4Q 2015)


LIQUIDITY

Company Name

Location

Brief
Description

Industry
Code

Industry Segment

Industry Group

Close
Date

Raised through
IPO (M)

Exchange/
Symbol

NovoCure Ltd.

United Kingdom

Developer of therapy for the


treatment of solid tumor cancers.

Biotechnology
Therapeutics

Biopharmaceuticals

Healthcare

2/10/2015

147.37

Nasdaq: NVCR

Mimecast Ltd.

United Kingdom

Software

Information
Technology

19/11/2015

70.42

NASDAQ: MIME

Advanced
Accelerator
Applications SA

France

Biopharmaceuticals

Healthcare

11/11/2015

68.15

NASDAQ: AAAP

Network/Systems
Provider of cloud security solutions. Management Software

Developer of molecular nuclear


medicine (MNM) products.

Biotechnology
Therapeutics

VENTURE CAPITAL REPORT

16

ABOUT US

Dow Jones VentureSource helps venture capitalists, corporate development executives, investment bankers and service provider find deal and
partnership opportunities, perform comprehensive due diligence and examine trends in venture capital investment, fund-raising and liquidity. It provides
accurate, comprehensive data on venture-backed companies including their investors and executives in every region, industry and stage of
development throughout the world.
The investment figures included in this release are based on aggregate findings of Dow Jones proprietary research and are contained in VentureSource.
This data was collected through survey of professional firms, interviews with company executives, and from secondary sources. These venture capital
statistics cover equity investments into early stage, innovative companies and do not include companies receiving funding solely from corporate,
individual, and/or government investors. Figures contained throughout the report current at time of editorial but are subject to change without notice.
No statement herein is to be construed as a recommendation to buy or sell securities or to provide investment advice.

VENTURE CAPITAL REPORT

17

ABOUT DOW JONES

Dow Jones is a global provider of news and business information, delivering content to consumers and organizations around the world across multiple
formats, including print digital, mobile and live events. Dow Jones has produced unrivaled quality content for more than 125 years and today has one of
the worlds largest newsgathering operations globally. It produces leading publications and products including the flagship Wall Street Journal,
Americas largest newspaper by paid circulation; Factiva, Barrons, MarketWatch, Financial News, DJX, Dow Jones Risk & Compliance, Dow Jones
Newswires, and Dow Jones VentureSource.

MEDIA CONTACT:
Hannah Syrocki
hannah.syrocki@dowjones.com
44 (0)20 7573 4059

VENTURE CAPITAL REPORT

18

You might also like